Peptide record

TPDB25704

Antibacterial Antiviral Toxicity modified_plain modified
42 source-reported length (unverified)
Basic Information
TPDB25704
Antibacterial Antiviral Toxicity
Anti-infective peptides Toxicity and safety peptides
Peptipedia
modified_plain
Yes
A modified multi-activity (Antibacterial, Antiviral, and Toxicity) peptide record curated from Peptipedia, without an available 3D structural model. Source-reported length: 42 (unverified).
Modified, details unspecified
Sequence
SLTQINTTLLDLTYEMLSLQQVVKALNESYIDLKELGSGSGX

Source notation is retained verbatim; residue notation and chemical identity have not been independently validated. The displayed length is source-reported and unverified.

Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
42 source-reported length (unverified)
Evidence Records 2 records
Evidence 1 Activity

Activity

<10% Cytotoxicity
Toxicity
10 µM
Cytotoxic
<10% Cytotoxicity | 10 | µM | target cell: Human embryonic kidney HEK293T cells

Target

Human embryonic kidney HEK293T cells

Source & Reference

NA
DBAASP
Inhibition of Coronavirus Entry In Vitro and Ex Vivo by a Lipid-Conjugated Peptide Derived from the SARS-CoV-2 Spike Glycoprotein HRC Domain. | MBio | 2020
Evidence 2 Activity

Activity

12% Cytotoxicity
Toxicity
10 µM
Cytotoxic
12% Cytotoxicity | 10 | µM | target cell: Vero E6 cells

Target

Vero E6 cells

Source & Reference

NA
DBAASP
Inhibition of Coronavirus Entry In Vitro and Ex Vivo by a Lipid-Conjugated Peptide Derived from the SARS-CoV-2 Spike Glycoprotein HRC Domain. | MBio | 2020